Linking calcium-channel isoforms to potential therapies

Francesco Belardetti1, Gerald W Zamponi

  • 1Neuromed Pharmaceuticals, Vancouver, Canada.

Current Opinion in Investigational Drugs (London, England : 2000)
|July 5, 2008
PubMed

Insights

Voltage-gated calcium channels are crucial for cardiovascular and nervous system functions. Research is advancing novel therapeutics targeting these channels for pain, epilepsy, and cardiovascular disorders.

Area of Science:

  • Pharmacology and Physiology
  • Cardiovascular Research
  • Neuroscience

Background:

  • Voltage-gated calcium channels (VGCCs) play vital roles in physiological processes.
  • Dysfunction of VGCCs is implicated in neurological and cardiovascular diseases.
  • VGCCs are established therapeutic targets for various conditions.

Purpose of the Study:

  • To review recent advancements in the development of calcium channel therapeutics.
  • To focus on therapeutic applications in pain, epilepsy, and cardiovascular disorders.
  • To highlight the potential of novel calcium channel modulators.

Main Methods:

  • Literature review of recent research and clinical trials.
  • Analysis of drug discovery efforts for calcium channel modulators.
  • Synthesis of findings related to therapeutic efficacy and safety.

Main Results:

  • Significant progress has been made in identifying and developing VGCC modulators.
  • Several novel compounds show promise for treating absence epilepsy and hypertension.
  • Emerging therapeutics are being explored for managing chronic pain conditions.

Conclusions:

  • Calcium channel therapeutics represent a promising area for treating neurological and cardiovascular diseases.
  • Continued research into novel calcium channel modulators is essential for addressing unmet medical needs.
  • Targeting VGCCs offers a viable strategy for developing effective treatments for pain, epilepsy, and cardiovascular dysfunction.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...